Nanomedicine: Industry-wise research
Source abstract
Abstract
Academic participation in nanomedicine research is welcomed by European industries. The recipe for success may or may not include creativity, but it will certainly require awareness of drug development and approval processes.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Innovative Microfluidic and Catalytic Techniques Innovation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (7)
Show source-provided references
1. http://cordis.europa.eu/nanotechnology.
2. Webster. R. et al. Drug Metab. Disp. 35, 9–16 (2007).10.1124/dmd.106.012419 ↗
3. http://ec.europa.eu/research/fp7.
4. www.epsrc.ac.uk/Publications/Corporate/StrategicPlan2006.
5. www.epsrc.ac.uk/ResearchFunding/Programmes.
6. Owens, J. Nature Rev. Drug Discov. 6, 99–101 (2007).10.1038/nrd2247 ↗
7. Nishiyama, N. et al. Nature Mater. 4, 934–941 (2005).10.1038/nmat1524 ↗